ID   THIL_HUMAN              Reviewed;         427 AA.
AC   P24752; B2R6H1; G3XAB4; Q96FG8;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   10-MAY-2017, entry version 186.
DE   RecName: Full=Acetyl-CoA acetyltransferase, mitochondrial;
DE            EC=2.3.1.9;
DE   AltName: Full=Acetoacetyl-CoA thiolase;
DE   AltName: Full=T2;
DE   Flags: Precursor;
GN   Name=ACAT1; Synonyms=ACAT, MAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1979337; DOI=10.1172/JCI114946;
RA   Fukao T., Yamaguchi S., Kano M., Orii T., Fujiki Y., Osumi T.,
RA   Hashimoto T.;
RT   "Molecular cloning and sequence of the complementary DNA encoding
RT   human mitochondrial acetoacetyl-coenzyme A thiolase and study of the
RT   variant enzymes in cultured fibroblasts from patients with 3-
RT   ketothiolase deficiency.";
RL   J. Clin. Invest. 86:2086-2092(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1684944; DOI=10.1016/0378-1119(91)90623-J;
RA   Kano M., Fukao T., Yamaguchi S., Orii T., Osumi T., Hashimoto T.;
RT   "Structure and expression of the human mitochondrial acetoacetyl-CoA
RT   thiolase-encoding gene.";
RL   Gene 109:285-290(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT PRO-5.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 50-78 AND 312-338.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 50-78 AND 231-243, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-174; LYS-181; LYS-251 AND
RP   LYS-263, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 35-427 IN COMPLEX WITH
RP   COENZYME A AND POTASSIUM, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES,
RP   CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=17371050; DOI=10.1021/bi6026192;
RA   Haapalainen A.M., Merilaeinen G., Pirilae P.L., Kondo N., Fukao T.,
RA   Wierenga R.K.;
RT   "Crystallographic and kinetic studies of human mitochondrial
RT   acetoacetyl-CoA thiolase: the importance of potassium and chloride
RT   ions for its structure and function.";
RL   Biochemistry 46:4305-4321(2007).
RN   [15]
RP   REVIEW ON 3KTD VARIANTS.
RX   PubMed=7749408; DOI=10.1002/humu.1380050203;
RA   Fukao T., Yamaguchi S., Orii T., Hashimoto T.;
RT   "Molecular basis of beta-ketothiolase deficiency: mutations and
RT   polymorphisms in the human mitochondrial acetoacetyl-coenzyme A
RT   thiolase gene.";
RL   Hum. Mutat. 5:113-120(1995).
RN   [16]
RP   VARIANT 3KTD ARG-183.
RX   PubMed=1346617; DOI=10.1172/JCI115608;
RA   Fukao T., Yamaguchi S., Orii T., Schutgens R.B.H., Osumi T.,
RA   Hashimoto T.;
RT   "Identification of three mutant alleles of the gene for mitochondrial
RT   acetoacetyl-coenzyme A thiolase. A complete analysis of two
RT   generations of a family with 3-ketothiolase deficiency.";
RL   J. Clin. Invest. 89:474-479(1992).
RN   [17]
RP   VARIANT 3KTD THR-380.
RX   PubMed=1715688; DOI=10.1016/0006-291X(91)91343-B;
RA   Fukao T., Yamaguchi S., Tomatsu S., Orii T., Frauendienst-Egger G.,
RA   Schrod L., Osumi T., Hashimoto T.;
RT   "Evidence for a structural mutation (347Ala to Thr) in a German family
RT   with 3-ketothiolase deficiency.";
RL   Biochem. Biophys. Res. Commun. 179:124-129(1991).
RN   [18]
RP   VARIANTS 3KTD ASP-158; MET-297 AND PRO-301.
RX   PubMed=7728148; DOI=10.1002/humu.1380050105;
RA   Wakazono A., Fukao T., Yamaguchi S., Hori T., Orii T., Lambert M.,
RA   Mitchell G.A., Lee G.W., Hashimoto T.;
RT   "Molecular, biochemical, and clinical characterization of
RT   mitochondrial acetoacetyl-coenzyme A thiolase deficiency in two
RT   further patients.";
RL   Hum. Mutat. 5:34-42(1995).
RN   [19]
RP   VARIANTS 3KTD SER-93; THR-312 AND PRO-333.
RX   PubMed=9744475;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:4<245::AID-HUMU5>3.0.CO;2-E;
RA   Fukao T., Nakamura H., Song X.-Q., Nakamura K., Orii K.E., Kohno Y.,
RA   Kano M., Yamaguchi S., Hashimoto T., Orii T., Kondo N.;
RT   "Characterization of N93S, I312T, and A333P missense mutations in two
RT   Japanese families with mitochondrial acetoacetyl-CoA thiolase
RT   deficiency.";
RL   Hum. Mutat. 12:245-254(1998).
CC   -!- FUNCTION: Plays a major role in ketone body metabolism.
CC   -!- CATALYTIC ACTIVITY: 2 acetyl-CoA = CoA + acetoacetyl-CoA.
CC       {ECO:0000255|PROSITE-ProRule:PRU10020,
CC       ECO:0000269|PubMed:17371050}.
CC   -!- ENZYME REGULATION: Activated by potassium ions, but not sodium
CC       ions. {ECO:0000269|PubMed:17371050}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4 uM for acetoacetyl coenzyme A
CC         {ECO:0000269|PubMed:17371050};
CC         KM=20 uM for coenzyme A {ECO:0000269|PubMed:17371050};
CC         KM=8 uM for 2-methylacetoacetyl coenzyme A
CC         {ECO:0000269|PubMed:17371050};
CC         KM=508 uM for acetyl coenzyme A {ECO:0000269|PubMed:17371050};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:17371050}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24752-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24752-2; Sequence=VSP_056844, VSP_056845;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Succinylation at Lys-268, adjacent to a coenzyme A binding
CC       site. Desuccinylated by SIRT5 (By similarity). {ECO:0000250}.
CC   -!- DISEASE: 3-ketothiolase deficiency (3KTD) [MIM:203750]: An inborn
CC       error of isoleucine catabolism characterized by intermittent
CC       ketoacidotic attacks associated with unconsciousness. Some
CC       patients die during an attack or are mentally retarded. Urinary
CC       excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic
CC       acid, triglylglycine, butanone is increased. It seems likely that
CC       the severity of this disease correlates better with the
CC       environmental or acquired factors than with the ACAT1 genotype.
CC       {ECO:0000269|PubMed:1346617, ECO:0000269|PubMed:1715688,
CC       ECO:0000269|PubMed:7728148, ECO:0000269|PubMed:9744475}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the thiolase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90228; BAA14278.1; -; mRNA.
DR   EMBL; D10511; BAA01387.1; -; Genomic_DNA.
DR   EMBL; AK312574; BAG35468.1; -; mRNA.
DR   EMBL; AP002433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67104.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67105.1; -; Genomic_DNA.
DR   EMBL; BC010942; AAH10942.1; -; mRNA.
DR   CCDS; CCDS8339.1; -. [P24752-1]
DR   PIR; JH0255; JH0255.
DR   RefSeq; NP_000010.1; NM_000019.3. [P24752-1]
DR   UniGene; Hs.232375; -.
DR   PDB; 2F2S; X-ray; 2.00 A; A/B/C/D=41-427.
DR   PDB; 2IB7; X-ray; 2.05 A; A/B/C/D=34-427.
DR   PDB; 2IB8; X-ray; 1.85 A; A/B/C/D=34-427.
DR   PDB; 2IB9; X-ray; 2.05 A; A/B/C/D=34-427.
DR   PDB; 2IBU; X-ray; 1.90 A; A/B/C/D=34-427.
DR   PDB; 2IBW; X-ray; 1.90 A; A/B/C/D=34-427.
DR   PDB; 2IBY; X-ray; 1.85 A; A/B/C/D=34-427.
DR   PDBsum; 2F2S; -.
DR   PDBsum; 2IB7; -.
DR   PDBsum; 2IB8; -.
DR   PDBsum; 2IB9; -.
DR   PDBsum; 2IBU; -.
DR   PDBsum; 2IBW; -.
DR   PDBsum; 2IBY; -.
DR   ProteinModelPortal; P24752; -.
DR   SMR; P24752; -.
DR   BioGrid; 106556; 61.
DR   IntAct; P24752; 6.
DR   MINT; MINT-5000530; -.
DR   STRING; 9606.ENSP00000265838; -.
DR   ChEMBL; CHEMBL2616; -.
DR   DrugBank; DB00795; Sulfasalazine.
DR   SwissLipids; SLP:000000701; -.
DR   iPTMnet; P24752; -.
DR   PhosphoSitePlus; P24752; -.
DR   SwissPalm; P24752; -.
DR   BioMuta; ACAT1; -.
DR   DMDM; 135755; -.
DR   REPRODUCTION-2DPAGE; IPI00030363; -.
DR   UCD-2DPAGE; P24752; -.
DR   EPD; P24752; -.
DR   MaxQB; P24752; -.
DR   PaxDb; P24752; -.
DR   PeptideAtlas; P24752; -.
DR   PRIDE; P24752; -.
DR   TopDownProteomics; P24752-1; -. [P24752-1]
DR   DNASU; 38; -.
DR   Ensembl; ENST00000265838; ENSP00000265838; ENSG00000075239. [P24752-1]
DR   Ensembl; ENST00000299355; ENSP00000299355; ENSG00000075239. [P24752-2]
DR   GeneID; 38; -.
DR   KEGG; hsa:38; -.
DR   UCSC; uc001pjw.2; human. [P24752-1]
DR   CTD; 38; -.
DR   DisGeNET; 38; -.
DR   GeneCards; ACAT1; -.
DR   HGNC; HGNC:93; ACAT1.
DR   HPA; HPA004428; -.
DR   HPA; HPA007569; -.
DR   MalaCards; ACAT1; -.
DR   MIM; 203750; phenotype.
DR   MIM; 607809; gene.
DR   neXtProt; NX_P24752; -.
DR   OpenTargets; ENSG00000075239; -.
DR   Orphanet; 134; Ketoacidosis due to beta-ketothiolase deficiency.
DR   PharmGKB; PA24431; -.
DR   eggNOG; KOG1390; Eukaryota.
DR   eggNOG; COG0183; LUCA.
DR   GeneTree; ENSGT00390000009412; -.
DR   HOGENOM; HOG000012238; -.
DR   HOVERGEN; HBG003112; -.
DR   InParanoid; P24752; -.
DR   KO; K00626; -.
DR   OMA; EPIDFPV; -.
DR   OrthoDB; EOG091G09C6; -.
DR   PhylomeDB; P24752; -.
DR   TreeFam; TF300650; -.
DR   BioCyc; MetaCyc:HS01167-MONOMER; -.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   Reactome; R-HSA-77108; Utilization of Ketone Bodies.
DR   Reactome; R-HSA-77111; Synthesis of Ketone Bodies.
DR   ChiTaRS; ACAT1; human.
DR   EvolutionaryTrace; P24752; -.
DR   GeneWiki; ACAT1; -.
DR   GenomeRNAi; 38; -.
DR   PRO; PR:P24752; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000075239; -.
DR   CleanEx; HS_ACAT1; -.
DR   ExpressionAtlas; P24752; baseline and differential.
DR   Genevisible; P24752; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0003985; F:acetyl-CoA C-acetyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0016830; F:carbon-carbon lyase activity; IDA:BHF-UCL.
DR   GO; GO:0050662; F:coenzyme binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0016885; F:ligase activity, forming carbon-carbon bonds; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0046356; P:acetyl-CoA catabolic process; IDA:BHF-UCL.
DR   GO; GO:0060612; P:adipose tissue development; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0015937; P:coenzyme A biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015936; P:coenzyme A metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IBA:GO_Central.
DR   GO; GO:0006550; P:isoleucine catabolic process; IMP:BHF-UCL.
DR   GO; GO:0046951; P:ketone body biosynthetic process; TAS:Reactome.
DR   GO; GO:0046952; P:ketone body catabolic process; IMP:BHF-UCL.
DR   GO; GO:1902224; P:ketone body metabolic process; IC:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0072229; P:metanephric proximal convoluted tubule development; IEA:Ensembl.
DR   GO; GO:1902860; P:propionyl-CoA biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020610; Thiolase_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   PIRSF; PIRSF000429; Ac-CoA_Ac_transf; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   TIGRFAMs; TIGR01930; AcCoA-C-Actrans; 1.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
DR   PROSITE; PS00099; THIOLASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Metal-binding; Mitochondrion; Polymorphism; Potassium;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     33       Mitochondrion. {ECO:0000250}.
FT   CHAIN        34    427       Acetyl-CoA acetyltransferase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000034085.
FT   REGION      258    260       Coenzyme A binding.
FT   ACT_SITE    126    126       Acyl-thioester intermediate.
FT                                {ECO:0000305}.
FT   ACT_SITE    385    385       Proton acceptor. {ECO:0000305}.
FT   ACT_SITE    413    413       Proton acceptor. {ECO:0000305}.
FT   METAL       219    219       Potassium. {ECO:0000269|PubMed:17371050}.
FT   METAL       280    280       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:17371050}.
FT   METAL       281    281       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:17371050}.
FT   METAL       283    283       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:17371050}.
FT   METAL       381    381       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:17371050}.
FT   BINDING     219    219       Coenzyme A.
FT                                {ECO:0000269|PubMed:17371050}.
FT   BINDING     263    263       Coenzyme A.
FT                                {ECO:0000269|PubMed:17371050}.
FT   BINDING     284    284       Coenzyme A.
FT                                {ECO:0000269|PubMed:17371050}.
FT   MOD_RES      66     66       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES      66     66       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES      78     78       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     174    174       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     174    174       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     181    181       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     181    181       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     190    190       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     190    190       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     202    202       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     202    202       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     223    223       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     223    223       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     230    230       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     230    230       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     243    243       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     251    251       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     257    257       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     263    263       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     263    263       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     266    266       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     268    268       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     273    273       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   MOD_RES     338    338       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZT1}.
FT   VAR_SEQ     146    162       DVMVAGGMESMSNVPYV -> IKQETGSLAKICCHVRR
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056844.
FT   VAR_SEQ     163    427       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056845.
FT   VARIANT       5      5       A -> P (in dbSNP:rs3741056).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_007496.
FT   VARIANT      85     85       Missing (in 3KTD).
FT                                /FTId=VAR_007497.
FT   VARIANT      93     93       N -> S (in 3KTD; 10% activity;
FT                                dbSNP:rs120074145).
FT                                {ECO:0000269|PubMed:9744475}.
FT                                /FTId=VAR_007498.
FT   VARIANT     152    152       G -> A (in 3KTD; dbSNP:rs762991875).
FT                                /FTId=VAR_007499.
FT   VARIANT     158    158       N -> D (in 3KTD; no activity;
FT                                dbSNP:rs148639841).
FT                                {ECO:0000269|PubMed:7728148}.
FT                                /FTId=VAR_007500.
FT   VARIANT     183    183       G -> R (in 3KTD; no activity;
FT                                dbSNP:rs120074141).
FT                                {ECO:0000269|PubMed:1346617}.
FT                                /FTId=VAR_007501.
FT   VARIANT     297    297       T -> M (in 3KTD; 10% normal activity).
FT                                {ECO:0000269|PubMed:7728148}.
FT                                /FTId=VAR_007502.
FT   VARIANT     301    301       A -> P (in 3KTD; 5% normal activity).
FT                                {ECO:0000269|PubMed:7728148}.
FT                                /FTId=VAR_007503.
FT   VARIANT     312    312       I -> T (in 3KTD; 10% activity;
FT                                dbSNP:rs120074146).
FT                                {ECO:0000269|PubMed:9744475}.
FT                                /FTId=VAR_007504.
FT   VARIANT     333    333       A -> P (in 3KTD; no activity;
FT                                dbSNP:rs120074147).
FT                                {ECO:0000269|PubMed:9744475}.
FT                                /FTId=VAR_007505.
FT   VARIANT     379    379       G -> V (in 3KTD; dbSNP:rs120074143).
FT                                /FTId=VAR_007506.
FT   VARIANT     380    380       A -> T (in 3KTD; 7% normal activity;
FT                                dbSNP:rs120074140).
FT                                {ECO:0000269|PubMed:1715688}.
FT                                /FTId=VAR_007507.
FT   CONFLICT    340    340       V -> M (in Ref. 2; BAA01387).
FT                                {ECO:0000305}.
FT   CONFLICT    346    346       D -> N (in Ref. 2; BAA01387).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       A -> S (in Ref. 2; BAA01387).
FT                                {ECO:0000305}.
FT   CONFLICT    412    412       I -> F (in Ref. 2; BAA01387).
FT                                {ECO:0000305}.
FT   STRAND       42     49       {ECO:0000244|PDB:2IB8}.
FT   TURN         58     61       {ECO:0000244|PDB:2IB8}.
FT   HELIX        64     79       {ECO:0000244|PDB:2IB8}.
FT   HELIX        83     85       {ECO:0000244|PDB:2IB8}.
FT   STRAND       88     92       {ECO:0000244|PDB:2IB8}.
FT   HELIX       103    110       {ECO:0000244|PDB:2IB8}.
FT   STRAND      119    123       {ECO:0000244|PDB:2IB8}.
FT   HELIX       125    127       {ECO:0000244|PDB:2IB8}.
FT   HELIX       128    141       {ECO:0000244|PDB:2IB8}.
FT   STRAND      146    155       {ECO:0000244|PDB:2IB8}.
FT   HELIX       156    158       {ECO:0000244|PDB:2IB8}.
FT   STRAND      161    163       {ECO:0000244|PDB:2IB8}.
FT   STRAND      165    167       {ECO:0000244|PDB:2IB8}.
FT   STRAND      173    177       {ECO:0000244|PDB:2IB8}.
FT   HELIX       178    182       {ECO:0000244|PDB:2IB8}.
FT   TURN        187    190       {ECO:0000244|PDB:2IB8}.
FT   HELIX       193    204       {ECO:0000244|PDB:2IB8}.
FT   HELIX       208    227       {ECO:0000244|PDB:2IB8}.
FT   TURN        228    234       {ECO:0000244|PDB:2IB8}.
FT   STRAND      238    240       {ECO:0000244|PDB:2IB8}.
FT   STRAND      248    250       {ECO:0000244|PDB:2IB8}.
FT   HELIX       255    257       {ECO:0000244|PDB:2IB8}.
FT   TURN        261    263       {ECO:0000244|PDB:2IB8}.
FT   HELIX       264    266       {ECO:0000244|PDB:2IB8}.
FT   STRAND      273    275       {ECO:0000244|PDB:2IB8}.
FT   TURN        280    282       {ECO:0000244|PDB:2IB8}.
FT   STRAND      287    297       {ECO:0000244|PDB:2IB8}.
FT   HELIX       298    303       {ECO:0000244|PDB:2IB8}.
FT   STRAND      310    319       {ECO:0000244|PDB:2IB8}.
FT   HELIX       322    327       {ECO:0000244|PDB:2IB8}.
FT   HELIX       328    340       {ECO:0000244|PDB:2IB8}.
FT   HELIX       344    346       {ECO:0000244|PDB:2IB8}.
FT   STRAND      347    352       {ECO:0000244|PDB:2IB8}.
FT   HELIX       357    367       {ECO:0000244|PDB:2IB8}.
FT   HELIX       371    373       {ECO:0000244|PDB:2IB8}.
FT   HELIX       380    383       {ECO:0000244|PDB:2IB8}.
FT   TURN        387    389       {ECO:0000244|PDB:2IB8}.
FT   HELIX       390    401       {ECO:0000244|PDB:2IB8}.
FT   STRAND      407    414       {ECO:0000244|PDB:2IB8}.
FT   TURN        415    417       {ECO:0000244|PDB:2IB8}.
FT   STRAND      418    426       {ECO:0000244|PDB:2IB8}.
SQ   SEQUENCE   427 AA;  45200 MW;  2E81168EB39D0142 CRC64;
     MAVLAALLRS GARSRSPLLR RLVQEIRYVE RSYVSKPTLK EVVIVSATRT PIGSFLGSLS
     LLPATKLGSI AIQGAIEKAG IPKEEVKEAY MGNVLQGGEG QAPTRQAVLG AGLPISTPCT
     TINKVCASGM KAIMMASQSL MCGHQDVMVA GGMESMSNVP YVMNRGSTPY GGVKLEDLIV
     KDGLTDVYNK IHMGSCAENT AKKLNIARNE QDAYAINSYT RSKAAWEAGK FGNEVIPVTV
     TVKGQPDVVV KEDEEYKRVD FSKVPKLKTV FQKENGTVTA ANASTLNDGA AALVLMTADA
     AKRLNVTPLA RIVAFADAAV EPIDFPIAPV YAASMVLKDV GLKKEDIAMW EVNEAFSLVV
     LANIKMLEID PQKVNINGGA VSLGHPIGMS GARIVGHLTH ALKQGEYGLA SICNGGGGAS
     AMLIQKL
//
